Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of

Gastroenterology
|February 1, 1985
PubMed

Insights

Diabetic gastroparesis is linked to absent gut motility patterns and high motilin levels. Metoclopramide restores motility in these patients, irrespective of motilin concentration changes.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic gastroparesis is characterized by abnormal gastrointestinal motility.
  • The role of plasma motilin concentration oscillations in this condition is not fully understood.

Purpose of the Study:

  • To investigate if abnormal plasma motilin oscillations cause motility issues in diabetic gastroparesis.
  • To examine metoclopramide's effects on plasma motilin and gastrointestinal motility in these patients.

Main Methods:

  • Measured plasma motilin concentration and gastrointestinal motility in healthy controls and diabetic gastroparesis patients.
  • Administered metoclopramide to assess its impact on motility and motilin levels.

Main Results:

  • Diabetic gastroparesis patients lacked normal interdigestive migrating motor complex (phase III activity).
  • Patients exhibited higher basal motilin concentrations with normal fluctuations.
  • Metoclopramide induced phase III activity in both groups, but motilin levels decreased in patients versus increased in controls.

Conclusions:

  • Diabetic gastroparesis involves absent antral interdigestive migrating motor complex and elevated, but normally fluctuating, plasma motilin.
  • Metoclopramide effectively initiates gastrointestinal motility in diabetic gastroparesis independently of plasma motilin levels.

Related Concept Videos

Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Intestinal Phase of Digestion01:29

Intestinal Phase of Digestion

The intestinal phase of digestion is the third and final stage of the digestive process, occurring after the cephalic and gastric phases. It begins when chyme, a partially digested mixture of food and digestive enzymes, enters the small intestine from the stomach. This phase is crucial for nutrient absorption and involves complex hormonal and enzymatic interactions.
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...